Sideline Gold on Fe...
Health Care: Drugs
Pfizer Inc (PFE: NYSE)
$29.10 -0.30 | -1.02%
06/19/13 - 04:01 PM ET
Insider Trading
| Historical Data | Current | 1 Mo. Ago | 2 Mo. Ago | 3 Mo. Ago | 4 Mo. Ago | 5 Mo. Ago | 6 Mo. Ago |
|---|---|---|---|---|---|---|---|
| Net Insider Transaction | -550,950 | -337,802 | -349,772 | -55,821 | -44,311 | -32,341 | -15,242 |
| Shares Bought | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shares Sold | 550,950 | 337,802 | 349,772 | 55,821 | 44,311 | 32,341 | 15,242 |
Institutional Trading
| Historical Data | Current | 1 Mo. Ago | 2 Mo. Ago | 3 Mo. Ago | 4 Mo. Ago | 5 Mo. Ago | 6 Mo. Ago |
|---|---|---|---|---|---|---|---|
| Total Shares Held | 5.04B | 5.03B | 5.15B | 5.14B | 5.23B | 5.29B | 5.31B |
| Shares Bought | 204.27M | 201.31M | 227.35M | 234.16M | 230.65M | 293.37M | 296.99M |
| Shares Sold | 304.69M | 304.89M | 231.91M | 240.06M | 245.86M | 264.51M | 253.32M |
Portfolios with PFE
- Portfolio NameUser Type
- Userchrisnash69 Portfolio 1
- ContributorHigh Volume Technicals for ...
- ContributorHigh Volume Technicals for ...
- UserQuicksilver55
- ContributorStocks Rising On Unusual Vo...
- Userdennis diamonds
- Userdennis all star
- UserBUYS
- UserThe Best Dividend Stocks
- ContributorHigh Volume Technicals for ...
Latest PFE Headlines from TheStreet
- 5 Drugs Stocks Driving The Industry Higher 06.19.13 | 01:06 pm
- Amarin: FDA Panel Date, Misplaced Hype For Fixed-Dose Combo 06.19.13 | 11:06 am
- Pfizer Inc (PFE): Today's Featured Drugs Winner 06.13.13 | 05:06 pm
- Dow Today: Pfizer (PFE) Higher 06.13.13 | 12:06 pm
- It's Raining Yen, Stocks Soaked
06.13.13 | 08:06 am - 5 Big Trades for a Ping-Pong Market 06.13.13 | 06:06 am
- Dow Today: Pfizer (PFE) Higher 06.12.13 | 12:06 pm
- Cooper Tire Sells to Apollo Tyres 06.12.13 | 11:06 am
- Cooper Tire Is Bought for $2.22 Billion: Ahead of the Ticker 06.12.13 | 10:06 am
- 4 Stocks Boosting The Drugs Industry Higher 06.11.13 | 01:06 pm
Press Releases for PFE
- Pharmaceutical Companies, Investor Coalition Develop Industry Standard-Setting Principles For Recoupment Policies Covering Major Compliance Failures - PR Newswire 04.04.13 | 08:04 am
- Pfizer’s BOSULIF® (bosutinib) Receives Conditional Marketing Authorization From The European Commission - Business Wire 03.28.13 | 03:03 am
- Pfizer Invites Public To View And Listen To Webcast Of April 30 Conference Call With Analysts - Business Wire 03.26.13 | 10:03 am
- XELJANZ® (tofacitinib Citrate) Approved In Japan For The Treatment Of Adults With Rheumatoid Arthritis (RA) - Business Wire 03.25.13 | 07:03 am
- New Trial Results Support Treatment With Inspra (eplerenone) Within First 24 Hours Of Symptoms, In Addition To Standard Therapy, In Patients With Acute STEMI Without Heart Failure. - Business Wire 03.10.13 | 02:03 pm
- United States Patent & Trademark Office Grants Pfizer Reissue Patent For Celebrex® (celecoxib Capsules) - Business Wire 03.05.13 | 09:03 am
- Pfizer Presents Phase 3 Safety And Immunogenicity Data On Prevnar 13® In Adults With HIV - Business Wire 03.04.13 | 04:03 pm
- Top-Line Data Show Lyrica Met Primary Endpoint In Clinical Trial As Adjunctive Therapy Versus Levetiracetam In Patients With Partial Onset Seizures - Business Wire 02.21.13 | 08:02 am
- Pfizer Invites Public To Listen To Webcast Of Pfizer Discussion At Healthcare Conference - Business Wire 02.19.13 | 11:02 am
- Pfizer Inc. Issues Statement On ZoetisTM IPO - Business Wire 02.01.13 | 09:02 am
Partner Headlines for PFE
- Innovation: Pharmaceutical groups become victims of their own success - Financial Times 06.19.13 | 09:06 pm
- Sustainable healthcare: trends urge need to put prevention before cure - Financial Times 06.19.13 | 09:06 pm
- Look For Stable Earnings When Scouting Dividend Stocks - Investor's Business Daily 06.19.13 | 05:06 pm
- Amgen In Focus - Seeking Alpha 06.19.13 | 09:06 am
- R&D Spending Can Be A Game-Changer For Some Stocks - Investor's Business Daily 06.17.13 | 05:06 pm
- Penny-Wise, Pound-Foolish Stem Cell Stocks - Seeking Alpha 06.14.13 | 09:06 am
- $2.15B Settlement for Pfizer's Protonix - Analyst Blog - Zacks 06.13.13 | 11:06 pm
- 2 Healthcare Companies With Recent Intensive Insider Selling - Seeking Alpha 06.13.13 | 09:06 am
- CRL for AVEO/ALPMY's Tivozanib - Analyst Blog - Zacks 06.13.13 | 12:06 am
- Teva and Sun Pharma fined $2.15bn for patent breach - Financial Times 06.12.13 | 10:06 pm
